Rising Infertility Rates Driving Growth Of The Chorionic Gonadotropin Market: A Key Driver Powering Chorionic Gonadotropin Market Growth In 2025

The Chorionic Gonadotropin Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Current Chorionic Gonadotropin Market Size and Its Estimated Growth Rate?
Over the recent years, the market size of chorionic gonadotropin has consistently expanded. The market is projected to increase from $1,260 million in 2024 to reach $1,340 million in 2025, growing at a compound annual growth rate (CAGR) of 4.4%. The historical growth can be linked to a heightened awareness of hCG among healthcare practitioners and patients, the increase in its usage for treating hormonal imbalance disorders, augmented affordability, improvements in health care infrastructure, and a surge in the demand for assisted reproduction.

The market for chorionic gonadotropin is predicted to experience consistent expansion in the coming years, reaching a market size of $1,710 million in 2029 with a CAGR of 4%. This expected growth can be linked to the escalating incidence of infertility issues, improved understanding of reproductive health, an increasing preference for assisted reproductive technologies, a growing number of hypogonadism cases among the older population, and the widening healthcare infrastructure. The forecast period also signals notable trends like technological progression, advances in recombinant technology, an upsurge in assisted reproductive technology, investments funneled into research and development, and innovations in drug delivery mechanisms and formulations.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19888

How Are Emerging Segments Shaping the Chorionic Gonadotropin Market Landscape?
The chorionic gonadotropin market covered in this report is segmented -

1) By Type: Human Chorionic Gonadotropin; Animal Chorionic Gonadotropin
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
3) By Therapeutic Application: Male Hypogonadism; Female Infertility Treatment; Oligospermic Treatment; Cryptorchidism Treatment; Chronic Pain; Other Therapeutic Applications
4) By End User: Research Institutions; Pharmaceutical Companies

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19888&type=smp

Which Growth Factors Are Influencing Chorionic Gonadotropin Market Expansion?
The heightened incidence of fertility problems is projected to boost the progression of the chorionic gonadotropin market. Infertility, which is defined as the incapacity to conceive a child following a year of routine, unprotected sex for couples below the age of 35 or post six months for those aged 35 and above, is on an upsurge mainly due to delayed child-rearing and life choices like smoking and obesity which adversely affect reproductive wellbeing. Chorionic Gonadotropin (hCG) plays a crucial role in combating these fertility problems by instigating ovulation in women, bolstering the luteal phase to sustain pregnancy, and prompting testosterone production in men to enhance their sperm count. For instance, in April 2023, the World Health Organization (WHO) reported that about 17.5% of adults globally, or 1 out of every 6 people, were dealing with fertility problems, indicating an urgent requirement for accessible and quality fertility care. Thus, the escalating incidence of fertility issues is fuelling the expansion of the chorionic gonadotropin market. The significant growth of assisted reproductive technologies is also aiding the expansion of the chorionic gonadotropin market. Assisted reproductive technologies (ART), which are medical procedures geared towards assisting individuals or couples who cannot naturally conceive, are gaining popularity due to increased infertility rates, medical breakthroughs, delayed child-rearing, and enhanced access. Chorionic gonadotropin (hCG) is used in these technologies to spark ovulation and support the luteal phase after the transfer of an embryo, guaranteeing successful fertilisation and early pregnancy. For instance, according to the US-based MJH Life Sciences, the number of ART cycles performed experienced significant growth, with the number of egg freezing cycles escalating from 24,560 in 2021 to 29,803 in 2022. Hence, the surge in assisted reproductive technologies is contributing to the growth of the chorionic gonadotropin market.

Who Are the Dominant Players Across Different Chorionic Gonadotropin Market Segments?
Major companies operating in the chorionic gonadotropin market include Ferring Pharmaceuticals

What Are the Latest Developing Trends in the Adcetris Market?
In the chorionic gonadotropin market, the principal trend is centered on creating innovative products like saliva-based pregnancy tests, to enhance ease of use, precision, and availability. Such a test uses a non-intrusive method of detecting pregnancy by examining a woman's saliva for the presence of human chorionic gonadotropin (hCG), a hormone released during the gestation period. For illustration, in June 2023, Salignostics, a biotech company based in Israel, pioneered the first-ever saliva-based pregnancy test globally. This novel product lets women confirm pregnancy using their saliva instead of urine by identifying the hCG hormone, with results obtainable in a time frame of 5 to 15 minutes. Salistick renders a more comfortable and handy testing process, permitting users to undertake the test at any location and share the experience with their significant others or family members.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/chorionic-gonadotropin-global-market-report

Which Geographic Regions Are Expected to Dominate the Chorionic Gonadotropin Market in the Coming Years?
North America was the largest region in the chorionic gonadotropin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chorionic gonadotropin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Chorionic Gonadotropin Market?
2. What is the CAGR expected in the Chorionic Gonadotropin Market?
3. What Are the Key Innovations Transforming the Chorionic Gonadotropin Industry?
4. Which Region Is Leading the Chorionic Gonadotropin Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.